PRIMARY STUDY
Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications
Key Findings: Dietary β-Caryophyllene may have therapeutic effects for use in treating insulin resistance, type 2 diabetes, obesity, hyperlipidemia, and diabetic complications.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): United Arab Emirates
Year of Pub: 2020
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Route of Administration: Oral (Ingestion)
Citation: Hashiesh HM, et al. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications. Nutrients. 2020; 12:(unknown pages). doi: 10.3390/nu12102963
Authors: Hashiesh HM, Meeran MFN, Sharma C, Sadek B, Kaabi JA, Ojha SK
